189 related articles for article (PubMed ID: 8778349)
1. [Synthetic inhibitors targeting serine and aspartic acid proteases].
Reboud-Ravaux MC; Boggetto ND; Doucet CE; de Rosny EH; Vergely IB; Thierry NM; Amour AJ
J Pharm Belg; 1996; 51(3):161-4. PubMed ID: 8778349
[TBL] [Abstract][Full Text] [Related]
2. Effect of protease inhibitors on exflagellation in Plasmodium falciparum.
Rupp I; Bosse R; Schirmeister T; Pradel G
Mol Biochem Parasitol; 2008 Apr; 158(2):208-12. PubMed ID: 18243365
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
4. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
Abdel-Rahman HM; Kimura T; Hidaka K; Kiso A; Nezami A; Freire E; Hayashi Y; Kiso Y
Biol Chem; 2004 Nov; 385(11):1035-9. PubMed ID: 15576323
[TBL] [Abstract][Full Text] [Related]
5. Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.
Blum A; Böttcher J; Sammet B; Luksch T; Heine A; Klebe G; Diederich WE
Bioorg Med Chem; 2008 Sep; 16(18):8574-86. PubMed ID: 18760609
[TBL] [Abstract][Full Text] [Related]
6. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.
Pochet L; Doucet C; Schynts M; Thierry N; Boggetto N; Pirotte B; Jiang KY; Masereel B; de Tullio P; Delarge J; Reboud-Ravaux M
J Med Chem; 1996 Jun; 39(13):2579-85. PubMed ID: 8691456
[TBL] [Abstract][Full Text] [Related]
7. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
[TBL] [Abstract][Full Text] [Related]
8. 5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitor.
Finch H; Pegg NA; McLaren J; Lowdon A; Bolton R; Coote SJ; Dyer U; Montana JG; Owen MR; Dowle M; Buckley D; Ross BC; Campbell C; Dix C; Mooney C; Man-Tang C; Patel C
Bioorg Med Chem Lett; 1998 Nov; 8(21):2955-60. PubMed ID: 9873654
[TBL] [Abstract][Full Text] [Related]
9. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
10. A spider (Araneus ventricosus) chymotrypsin inhibitor that acts as an elastase inhibitor and a microbial serine protease inhibitor.
Wan H; Lee KS; Kim BY; Yuan M; Zhan S; You H; Li J; Jin BR
Comp Biochem Physiol B Biochem Mol Biol; 2013 May; 165(1):36-41. PubMed ID: 23499942
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
Bhongade BA; Gouripur VV; Gadad AK
Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
Muthas D; Nöteberg D; Sabnis YA; Hamelink E; Vrang L; Samuelsson B; Karlén A; Hallberg A
Bioorg Med Chem; 2005 Sep; 13(18):5371-90. PubMed ID: 16054370
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.
Hoegl L; Korting HC; Klebe G
Pharmazie; 1999 May; 54(5):319-29. PubMed ID: 10368824
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
16. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
Ersmark K; Nervall M; Gutiérrez-de-Terán H; Hamelink E; Janka LK; Clemente JC; Dunn BM; Gogoll A; Samuelsson B; Qvist J; Hallberg A
Bioorg Med Chem; 2006 Apr; 14(7):2197-208. PubMed ID: 16307884
[TBL] [Abstract][Full Text] [Related]
17. Protease inhibitors: current status and future prospects.
Leung D; Abbenante G; Fairlie DP
J Med Chem; 2000 Feb; 43(3):305-41. PubMed ID: 10669559
[No Abstract] [Full Text] [Related]
18. Asymmetric preference of serine proteases toward phosphonate and phosphinate esters.
Walker B; Wharry S; Hamilton RJ; Martin SL; Healy A; Walker BJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1235-9. PubMed ID: 11027616
[TBL] [Abstract][Full Text] [Related]
19. Proteases--structures, mechanism and inhibitors.
Powers JC; Odake S; Oleksyszyn J; Hori H; Ueda T; Boduszek B; Kam C
Agents Actions Suppl; 1993; 42():3-18. PubMed ID: 8356929
[TBL] [Abstract][Full Text] [Related]
20. Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.
Banke IJ; Arlt MJ; Pennington C; Kopitz C; Steinmetzer T; Schweinitz A; Gansbacher B; Quigley JP; Edwards DR; Stürzebecher J; Krüger A
Biol Chem; 2003; 384(10-11):1515-25. PubMed ID: 14669995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
